Evidence map›Paper›PMID 31063442›Full record

ArticleHuman vaccines & immunotherapeutics2019

Is the function of the HBeAg really unknown?

David R Milich

Abstract readComment
In one paragraph

Article in Human vaccines & immunotherapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Hepatitis B virus e antigen and viral persistence.Current opinion in virology · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. [The Clinical Significance and Mechanism of the Effect for Hepatitis B Virus Protein on Host Immune].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

David R MilichDepartment of Immunology, Vaccine Research Institute of San Diego , San Diego , CA , USA.

Funding

A Therapeutic Vaccine for Chronic Hepatitis BR44AI088919 · NIAID · VLP BIOTECH, INC. · PI MILICH, DAVID R. · 2012 to 2020
$4.6M
NIAID NIH HHS R44 AI088919
6 · The paper itself

Abstract

The immune response to the hepatitis B virus (HBV) vaccine in newborns of hepatitis B e antigen (HBeAg)-positive or HBeAg-negative mothers is the subject of Huang et al. The authors report no correlation between the HBeAg status of the mothers/cord blood and the newborns immune response to the vaccine, but, unfortunately, draw unfounded conclusions regarding the tolerogenic potential of

Indexed as

Hepatitis BHepatitis B e AntigensAntibody FormationFemaleFetal BloodHepatitis B virusHumansInfantInfant, NewbornVaccinationHepatitis B e AntigenschronicityHBeAgHBV vaccineHepatitis B virusimmune tolerance

Identifiers

PMID31063442
PMCPMC6773382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.